Efficacy of Zinc in the Treatment of Pneumonia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00198666|
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : January 12, 2015
|Condition or disease||Intervention/treatment||Phase|
|Pneumonia||Drug: Zinc||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||299 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Efficacy of Zinc in the Treatment of Pneumonia in Hospitalized Children Less Than 2 Years of Age|
|Study Start Date :||September 2003|
|Actual Primary Completion Date :||August 2004|
|Actual Study Completion Date :||August 2004|
Children with severe pneumonia were randomly assigned to receive supplementation with elemental zinc.
No Intervention: Control
Children with severe pneumonia were randomly assigned to receive supplementation with placebo tablets.
- Duration of severe symptoms [ Time Frame: 2 years ]
- Time to recovery from severe pneumonia [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00198666
|Principal Investigator:||Mathuram Santosham, MD||Johns Hopkins Bloomberg School of Public Health|